Disease flare with gonadotrophin-releasing hormone (GnRH) analogues. How serious is it? (Q40901268)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Disease flare with gonadotrophin-releasing hormone (GnRH) analogues. How serious is it?	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8481213

retrieved

24 September 2017

review article

1 reference

stated in

Europe PubMed Central

title

Disease flare with gonadotrophin-releasing hormone (GnRH) analogues. How serious is it? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8481213

retrieved

24 September 2017

author name string

R Scaletscky

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8481213

retrieved

24 September 2017

J A Smith

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8481213

retrieved

24 September 2017

publication date

1 April 1993

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8481213

retrieved

24 September 2017

published in

Drug Safety

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8481213

retrieved

24 September 2017

volume

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8481213

retrieved

24 September 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8481213

retrieved

24 September 2017

page(s)

265-270

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8481213

retrieved

24 September 2017

cites work

Sudden death due to disease flare with luteinizing hormone-releasing hormone agonist therapy for carcinoma of the prostate.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

LHRH agonists--mechanism of action and effect on target tissues

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DES lead-in to use of luteinizing hormone releasing hormone analogs in treatment of metastatic carcinoma of prostate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic cancer of the prostate managed with buserelin versus buserelin plus cyproterone acetate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Priapism in hypogonadal men receiving gonadotropin releasing hormone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined treatment with buserelin and cyproterone acetate in metastatic prostatic carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgen suppression by a gonadotropin releasing hormone analogue in patients with metastatic carcinoma of the prostate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of LHRH Analogue (Zoladex) with Orchiectomy in Patients with Metastatic Prostatic Carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of metastatic prostatic cancer with a potent luteinizing hormone releasing hormone analogue

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gonadotrophin releasing hormone analogues for prostatic cancer: an overview.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oestrogen pre-treatment abolishes luteinising hormone-releasing hormone testosterone stimulation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine and clinical evaluation of 107 patients with advanced prostatic carcinoma under long-term pernasal buserelin or intramuscular decapeptyl depot treatment.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate carcinoma tumor size in rats decreases after administration of antagonists of luteinizing hormone-releasing hormone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease flare induced by D-Trp6-LHRH analogue in patients with metastatic prostatic cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of the Transient Adverse Effects of a Gonadotropin-Releasing Hormone Analogue (Buserelin) in Metastatic Prostatic Carcinoma by Administration of an Antiandrogen (Nilutamide)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of Different Types of Antiandrogens on Luteinizing Hormone-Releasing Hormone Analogue-Induced Testosterone Surge in Patients with Metastatic Carcinoma of the Prostate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical effects of gonadotropin-releasing hormone analogue in metastatic carcinoma of prostate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of diethylstilbestrol or orchiectomy with buserelin and with methotrexate plus diethylstilbestrol or orchiectomy in newly diagnosed patients with clinical stage D2 cancer of the prostate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8481213

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00002018-199308040-00001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8481213

retrieved

24 September 2017

Dimensions Publication ID

1029345624

0 references

PubMed publication ID

8481213

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8481213

retrieved

24 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40901268&oldid=2204073657"